• Inotropic therapy in patients with advanced heart failure: a clinical consensus statement from the Heart Failure Association of the European Society of Cardiology 

      Gustafsson, Finn; Damman, Kevin; Nalbantgil, Sanem; Van Laake, Linda W.; Tops, Laurens F.; Thum, Thomas; Adamopoulos, Stamatis; Bonios, Michael; Coats, Andrew J.S.; Crespo-Leiro, María Generosa; Mehra, Mandeep R.; Filippatos, Gerasimos; Hill, Loreena; Metra, Marco; Jankowska, Ewa; de Jonge, Nicolaas; Kaye, David; Masetti, Marco; Parissis, John; Milicic, Davor; Seferovic, Petar; Rosano, Giuseppe; Ben Gal, Tuvia (John Wiley & Sons, 2023-02-27)
      [Abstract] This clinical consensus statement reviews the use of inotropic support in patients with advanced heart failure. The current guidelines only support use of inotropes in the setting of acute decompensated heart ...
    • Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure 

      Crespo-Leiro, María Generosa; Caravaca Pérez, Pedro; González-Juanatey, J. R.; Nuche, Jorge; Matute-Blanco, Lucía; Serrano, Isabel; Martínez-Selles, Manuel; Vázquez García, Rafael; Martínez-Dolz, Luis; Gómez-Bueno, Manuel; Pascual Figal, Domingo; García-Osuna, Álvaro; Ordóñez-Llanos, Jordi; Cinca Cuscullola, Juan; Guerra, José M.; Delgado, Juan F. (Frontiers, 2022-04)
      [Abstract] Introduction: Galectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels and renal function has been observed, ...